[Federal Register: April 15, 1998 (Volume 63, Number 72)]
[Notices]               
[Page 18431-18432]
From the Federal Register Online via GPO Access [wais.access.gpo.gov]
[DOCID:fr15ap98-107]

-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Food and Drug Administration

 
Pulmonary-Allergy Drugs Advisory Committee Meeting; Cancellation

AGENCY: Food and Drug Administration, HHS.

ACTION: Notice.

-----------------------------------------------------------------------

SUMMARY: The Food and Drug Administration (FDA) is cancelling the 
meeting of the Pulmonary-Allergy Drugs Advisory Committee scheduled for 
April 20, 1998. The meeting was announced in the Federal Register of 
March 19, 1998 (63 FR 13413).

FOR FURTHER INFORMATION CONTACT: Leander B. Madoo, Center for Drug 
Evaluation and Research (HFD-21),

[[Page 18432]]

Food and Drug Administration, 5600 Fishers Lane, Rockville, MD 20857, 
301-443-5455, or FDA Advisory Committee Information Line, 1-800-741-
8138 (301-443-0572 in the Washington, DC area), code 12545.

    Dated: April 8, 1998.
Michael A. Friedman,
Deputy Commissioner for Operations.
[FR Doc. 98-9866 Filed 4-14-98; 8:45 am]
BILLING CODE 4160-01-F